BORGESON BLAKE sold 0.6% of their position (40K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $158.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/9/2026ACC: 0001856094-26-000011
Director
Since Apr 2021
-40K
Net shares
Net seller
$158.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
40K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−40K
Price / share
$3.96
Trade value
$158.50K
% of position
0.6%
7/7/2026
6.26M→6.22M
Total
Net shares
−40K
Net value
-$158.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/7/2026 | S · Sale | −40K | $3.96 | $158.50K | 0.6% | 6.26M | 6.22M |
| Total | −40K | -$158.50K | ||||||
Derivative Transactions0
No derivative transactions reported